Evidence map›Paper›PMID 42343275›Full record

ArticleBMC infectious diseases2026

Antimicrobial resistance patterns of isolated bacteria at Bukoba Regional Referral Hospital in Patients attended from 2019 to 2023.

Eustadius Kamugisha Felician, Tatu Ibrahimu, Sophia Mosha, Juma Kayenzi, George Mosha, Welington Mosses, Levi Minani, Vaileth Mkebezi, George Milambo, Jeremiah Seni and 1 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Eustadius Kamugisha FelicianDepartment of Laboratory and Pathology, Bukoba Regional Referral Hospital, Bukoba, Tanzania. eustadius.felician@yahoo.com.
Tatu IbrahimuDepartment of Pharmacy, Bukoba Regional Referral Hospital, Bukoba, Tanzania.
Sophia MoshaDepartment of Pediatrics, Bukoba Regional Referral Hospital, Bukoba, Tanzania.
Juma KayenziDepartment of Laboratory and Pathology, Bukoba Regional Referral Hospital, Bukoba, Tanzania.
George MoshaMedical Department, Bukoba Regional Referral Hospital, Bukoba, Tanzania.
Welington MossesDepartment of Laboratory and Pathology, Bukoba Regional Referral Hospital, Bukoba, Tanzania.
Levi MinaniDepartment of ICT, Bukoba Regional Referral Hospital, Bukoba, Tanzania.
Vaileth MkebeziDepartment of Pharmacy, Bukoba Regional Referral Hospital, Bukoba, Tanzania.
George MilamboDepartment of Pharmacy, Bukoba Regional Referral Hospital, Bukoba, Tanzania.
Jeremiah SeniCatholic University of Health and Allied Sciences, Mwanza, Tanzania.
Museleta NyakirotoSurgical Department, Bukoba Regional Referral Hospital, Bukoba, Tanzania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntimicrobial resistance (AMR) has emerged as a global public health concern, increasing morbidity, mortality, and healthcare costs. Limited surveillance data exist from regional referral hospitals in Tanzania, including Bukoba Regional Referral Hospital (BRRH). Understanding local AMR patterns is essential to guide empirical therapy and inform infection prevention and control strategies. This study aimed to determine the patterns, trends, and factors associated with AMR among bacterial isolates at BRRH between 2019 and 2023. METHODOLOGY: A retrospective cross-sectional study was conducted using laboratory records and patient files from Bukoba Regional Referral Hospital between January 2019 and December 2023. Clinical specimens were cultured, bacterial isolates identified using standard microbiological procedures, and antimicrobial susceptibility testing performed using the Kirby-Bauer disk diffusion method according to CLSI 2024 guidelines. Chi-square test was used to assess associations between bacterial isolates and prescribed antimicrobial agents, with statistical significance considered at P < 0.05.

resultsA total of 1,680 specimens were processed during the observation period, the proportion of specimens yielding pathogenic bacterial growth was 297 (17.7%) and 15 (0.9%) of culture samples were discarded due to contamination. The median age of patients was 28 years, with 58% female. Urine 110 (36.9%), pus 99 (33.2%), and stool 76 (25.5%) were the most common samples. Escherichia coli 60 (76.9%), Staphylococcus aureus 32 (86.5%), and Salmonella typhi 63 (100%) were the predominant isolates from urine, pus and stool samples respectively. E. coli showed high resistance to azithromycin (95.0%) and ampicillin (84.4%); S. aureus and coagulase-negative Staphylococci exhibited 100% and 90% resistance to penicillin, respectively. High levels of resistance to commonly used antimicrobial agents on Azithromycin 60 (88.2%), Ceftriaxone 118 (84.3%) and Ampicillin 82 (83.7%) were observed where 17.4% of patients were not prescribed antimicrobial agents despite culture positivity, while mismatches between susceptibility results and prescriptions were common.

conclusionThis study demonstrates a high prevalence of antimicrobial resistance among commonly isolated bacterial pathogens at Bukoba Regional Referral Hospital. Routine development of local antibiograms, strengthening antimicrobial stewardship programs, promoting rational antibiotic prescribing, and enhancing IPC practices are urgently needed to combat AMR at BRRH and similar settings.

Indexed as

Anti-Bacterial AgentsBacteriaBacterial InfectionsDrug Resistance, BacterialAdolescentAdultAgedChildChild, PreschoolCross-Sectional StudiesFemaleHumansInfantMaleMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial AgentsAntimicrobialBacteriaBukobaPatientsResistance

Identifiers

PMID42343275
PMCPMC13421999

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.